10th Anniversary Targeting Mitochondria 2019 Congress

A Mitochondrial Etiology of the Common Complex Diseases

Douglas C. Wallace, Center for Mitochondrial and Epigenomic Medicine, USA

Increased Hydrogen Peroxide and decreased Glutathione Redox potential may cause Dopaminergic Neurodegeneration in Parkin loss-of-function
Lori M. Buhlman, Midwestern University, USA

Stem cell-driven drug discovery of OXPHOS diseases

Alessandro Prigione, Max Delbrueck Center for Molecular Medicine, Germany

Mitochondrial Copper Toxicity with a Focus on Wilson Disease

Hans Zischka, Institute of Molecular Toxicology and Pharmacology, Germany

Selective segregation of mitochondria in asymmetric stem cell divisions
Pekka Katajisto, Center of Excellence in Stem Cell Metabolism, Finland

Mitochondrial Transplantation - From Animal Studies to Clinical Relevance
James D. McCully, Harvard Medical School, Boston Children's Hospital, USA

Cardiac glycosides modulate neuroblastoma stem cell survival by dysfunctional mitophagy
Marc Diederich, Seoul National University, South Korea

The cellular stress protein MNRR1/CHCHD2 and mitochondrial disease

Lawrence Grossman, Wayne State University, USA

Mitochondria-targeted low-molecular weight compounds for probing mitochondrial functions
Richard C. Hartley, University of Glasgow, United Kingdom

Mitochondria-targeted Nanocarriers for mitochondrial therapies
Shanta Dhar, University of Miami, USA

Introduction: Role of actin-regulating proteins on mitochondria
Cartrsten Culmsee, University of Marburg, Germany

T-cell metabolism and mitochondrial function
Alessia Angelin, Children's Hospital of Philadelphia, USA